Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

The influence of urinary macromolecules on calcium oxalate monohydrate crystal growth.

Lanzalaco AC, Singh RP, Smesko SA, Nancollas GH, Sufrin G, Binette M, Binette JP.

J Urol. 1988 Jan;139(1):190-5.

PMID:
3336094
2.

Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.

Costa-Bauzá A, Isern B, Perelló J, Sanchis P, Grases F.

Scand J Urol Nephrol. 2005;39(3):194-9.

PMID:
16118089
3.

Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins.

Hess B, Nakagawa Y, Coe FL.

Am J Physiol. 1989 Jul;257(1 Pt 2):F99-106.

PMID:
2750929
4.

Glycoprotein calcium oxalate crystal growth inhibitor in urine.

Worcester EM, Nakagawa Y, Coe FL.

Miner Electrolyte Metab. 1987;13(4):267-72. Review.

PMID:
3306319
5.

Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine.

Nakagawa Y, Abram V, Kézdy FJ, Kaiser ET, Coe FL.

J Biol Chem. 1983 Oct 25;258(20):12594-600.

6.

Effects of urinary macromolecules on the crystallization of calcium oxalate.

Tiselius HG, Fornander AM, Nilsson MA.

Urol Res. 1990;18(6):381-5.

PMID:
2100412
7.
8.

Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine.

Ebisuno S, Nishihata M, Inagaki T, Umehara M, Kohjimoto Y.

J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S436-40.

PMID:
10541279
9.

Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine.

Edyvane KA, Hibberd CM, Harnett RM, Marshall VR, Ryall RL.

Clin Chim Acta. 1987 Aug 31;167(3):329-38.

PMID:
3621616
10.

[Glycoprotein inhibitors of urinary calculi formation].

Berland Y, Dussol B.

Nephrologie. 1993;14(4):183-7. Review. French.

PMID:
8232713
11.
12.

The effects of citrate and urine on calcium oxalate crystal aggregation.

Tiselius HG, Fornander AM, Nilsson MA.

Urol Res. 1993;21(5):363-6.

PMID:
8279094
13.

Urinary calcium oxalate crystal growth inhibitors.

Worcester EM.

J Am Soc Nephrol. 1994 Nov;5(5 Suppl 1):S46-53. Review.

14.

Rapid method of measuring the inhibition of calcium-oxalate monohydrate growth in urine.

Baumann JM, Ackermann D, Affolter B.

Urol Res. 1990;18(3):219-22.

PMID:
2396351
15.

Crystallization conditions in urine of patients with idiopathic recurrent calcium nephrolithiasis and with hyperparathyroidism.

Baumann JM, Lauber K, Lustenberger FX, Wacker M, Zingg EJ.

Urol Res. 1985;13(4):169-74.

PMID:
4049602
16.

Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.

Costa-Bauzá A, Perelló J, Isern B, Sanchis P, Grases F.

BMC Urol. 2006 Jul 5;6:16.

17.

Defective urinary crystallization inhibition and urinary stone formation.

Carvalho M, Lulich JP, Osborne CA, Nakagawa Y.

Int Braz J Urol. 2006 May-Jun;32(3):342-8; discussion 349.

18.

The effect of saline bladder washings on calcium oxalate crystal growth and aggregation.

Edyvane KA, Ryall RL, Marshall VR.

J Urol. 1985 Jul;134(1):158-61.

PMID:
4009815
19.
20.

Does urinary oxalate interfere with the inhibitory role of glycosaminoglycans and semisynthetic sulfated polysaccharides in calcium oxalate crystallization?

Cao LC, Deng G, Boevé ER, Romijn JC, de Bruijn WC, Verkoelen CF, Schröder FH.

Eur Urol. 1997;31(4):485-92.

PMID:
9187912

Supplemental Content

Support Center